Bleomycin in xeroderma pigmentosum.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008171:Lung Diseases / Q000139:chemically induced* / Q000401:mortality / Q000473:pathology; D008297:Male; D011650:Pulmonary Alveoli / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D014983:Xeroderma Pigmentosum / Q000150:complications / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin